RSS FDA Approves Organon's VTAMA For Treatment Of Atopic Dermatitis

Currently reading:
 RSS FDA Approves Organon's VTAMA For Treatment Of Atopic Dermatitis

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
6,205
Likes
1,915
Credits
32,754©
Cash
0$
Organon (OGN) announced on Monday that the U.S. Food and Drug Administration (FDA) has granted approval for Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist, as an additional treatment option for atopic dermatitis (AD) in both adults and children aged 2 years and older. This approval was secured before the expected target action date of March 12, 2025 (PDUFA).

Kevin Ali, Chief Executive Officer of Organon, expressed, "With the FDA's green light for VTAMA cream in treating atopic dermatitis in both adults and children as young as 2 years, we now have a therapeutic option that promises effective skin clearance without any label warnings, precautions, contraindications, or restrictions on usage duration or the body surface area affected. Introducing this pioneering therapy underscores Organon's commitment to addressing significant unmet medical needs."

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips

Similar threads

Top Bottom